骨髓/淋巴瘤新生体与FGFR1重组和佩米加替尼布
Alessandro M Vannucchi1, Jay L Patel2, Jean-Jacques Kiladjian3
1Department of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Firenze, Italy.
Blood
|March 4, 2026
概括
与FGFR1重组 (M/LN-FGFR1) 的髓状/淋巴状瘤是罕见的癌症. 作为FGFR1抑制剂的佩米加替尼 (pemigatinib) 在治疗这些侵袭性疾病方面表现出前所未有的疗效,解决了关键的未满足需求.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 具有FGFR1重组 (M/LN-FGFR1) 的髓状/淋巴状瘤是一种罕见的异质性疾病.
- 这些瘤是FGFR1基因融合的结果,导致FGFR1信号不受控制.
- 目前的常规疗法在异性干细胞移植 (ASCT) 外提供了令人丧的生存结果.
研究的目的:
- 总结支持批准佩米加提尼布用于M/LN-FGFR的临床数据1.1.
- 为了突出佩米加西尼布在这个患者群体中前所未有的疗效.
主要方法:
- 对M/LN-FGFR1.1.中的佩米加替尼的临床试验数据的审查.
- 对米加替尼的疗效和安全性分析.
主要成果:
- 佩米加提尼布在患有M/LN-FGFR1.1.的患者中显示出前所未有的疗效.
- 该药物解决了这种罕见疾病的重大未满足的临床需求.
结论:
- 佩米加提尼布代表了对M/LN-FGFR1.1的显著治疗进展.
- 用FGFR1抑制剂进行向治疗为患有这些侵袭性瘤的患者提供了新的希望.
更多相关视频
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
22.6K
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.7K
相关概念视频
02:23Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
02:38Mitogens and the Cell Cycle
8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K